Vancouver, British Columbia, Canada, September 6, 2017 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative technologies for the cannabis industry, is pleased to announce the launch of Global Cannabis Apps Corporation (Australia) Pty Ltd. (“GCAC Australia”), a private Australian company held 61% by GCAC.
GCAC Australia will specialise in developing special projects using cutting edge technologies to collect big data – important for clinical trials, university research teams, the medical community and regulators – in the medical cannabis space.
An early project for GCAC Australia will include a partnership with BuddingTech, a leading medical cannabis accelerator focused on technology based opportunities aimed at providing better data for clinical trials to improve outcomes for all stakeholders in the medical cannabis industry. Collaborating with BuddingTech, GCAC Australia will task a software team with the development of both a ‘Blockchain’ technology and a regulatory Artificial Intelligence technology for the medical cannabis industry in order to meet Australian regulations.
BuddingTech is led by Adam Miller, its founder and Managing Director, and Blaise Bratter, its Chief Development Officer. Messrs. Miller and Bratter, as founders of the Medical Cannabis Council of Australia – Australia’s peak national industry body for medical cannabis – are widely regarded in Australia within the medical cannabis space and both will be joining GCAC Australia in executive roles.
Jason Webb, former managing director of GCAC’s operations in Australia, will become Chief Executive Officer of GCAC Australia and GCAC’s Chief Executive Officer, Brad Moore, will join GCAC Australia as Chairman of its Board of Directors.
“GCAC Australia aims to be an important facilitator for special projects involving data for the medical cannabis industry in Australia and beyond,” says Jason Webb. “We have a great team, unmatched assets and significant opportunities ahead. We are excited to be at the forefront of data and technology in this important space.”
“I am delighted to have secured our key Australian partners as part of GCAC’s global delivery,” says Brad Moore, Chief Executive Officer of GCAC. “GCAC Australia will set the framework for our global roll out. By establishing the most trusted data supply for the medical cannabis industry in one of the toughest regulatory environments, we will have a model that we can expand into other (42) emerging medical cannabis countries.”
“Our GCAC Australian team have deep medical cannabis, Blockchain, and Artificial Intelligence credentials with an international delivery network, and Australia is setting the highest regulatory standard for medical cannabis programs and development of future therapeutic products,” states Mr. Moore.
GCAC Australia will be licensed to distribute GCAC’s proprietary ‘Pain to Strain’ model, driven by 10+ years of field research on patient experiences from the Canadian medical program, which will provide the framework of the Australian program.
Jason Webb stated, “Anecdotal data derived from the ‘Pain To Strain’ database and the GCAC apps (including ‘Prescriptii’ and ‘CannaLife’) will be significant for ongoing research and will complement big data derived from special projects developed for clinical trials (and regulators) in Australia.”
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative mobile applications. Used in over 25 countries, GCAC’s apps facilitate the proliferation of digital conversations by like-minded people. Managed by digital industry experts, GCAC is focused on viral global expansion by providing the best user experience in each target market. Its leading mobile platforms are Citizen Green, a family of apps dedicated to the digital world of all things cannabis; Foro, a peer-topeer mobile ecommerce student marketplace; Opinit, an app that enables users to socially share their favourite online sentiment-driven content; and Truth, a one-to-one anonymous messaging app.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Chief Executive Officer
For more information, please contact:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.